The management of melanoma and nonmelanoma skin cancer: A review for the primary care physician

Mayo Clinic Proceedings

Volumn 76, Issue 12, 2001, Pages 1253-1265

  Martinez, Juan Carlos ^a   Otley, Clark C ^a  

^a MAYO CLINIC COLLEGE OF MEDICINE   (United States)

Author keywords

BCC = basal cell carcinoma; ED C = electrodesiccation and curettage; NMSC = nonmelanoma skin cancer; SCC = squamous cell carcinoma

Indexed keywords

DACARBAZINE; INTERLEUKIN 2;

ALGORITHM; BASAL CELL CARCINOMA; CANCER CLASSIFICATION; CANCER RADIOTHERAPY; CANCER RISK; CANCER STAGING; CANCER SURGERY; CLINICAL FEATURE; FOLLOW UP; HISTOPATHOLOGY; HUMAN; MELANOMA; PRACTICE GUIDELINE; PRIMARY HEALTH CARE; REVIEW; RISK FACTOR; SENTINEL LYMPH NODE; SKIN CANCER; SQUAMOUS CELL CARCINOMA; TREATMENT PLANNING; TUMOR BIOPSY;

EID: 0035205338     PISSN: 00256196     EISSN: None     Source Type: Journal    
DOI: 10.4065/76.12.1253     Document Type: Article

References (54)

1. Overview of skin cancer detection and prevention for the primary care physician
2. Comparison of treatment modalities for basal cell carcinoma
3. Prognostic factors for local recurrence, metastasis, and survival rates in squamous cell carcinoma of the skin, ear, and lip: Implications for treatment modality selection
4. Histologic evolution of recurrent basal cell carcinoma and treatment implications
5. Squamous cell carcinoma: A population-based incidence study in Rochester, Minn
6. Squamous cell carcinoma of the skin (excluding lip and oral mucosa)
7. Mohs surgery is the treatment of choice for recurrent (previously treated) basal cell carcinoma
8. Recurrence rates of treated basal cell carcinomas, part 2: Curettage-electrodesiccation
9. Long-term recurrence rates in previously untreated (primary) basal cell carcinoma: Implications for patient follow-up
10. Multivariate risk score for recurrence of cutaneous basal cell carcinomas
11. Mohs surgery: Technique, indications, applications, and the future
12. The National Comprehensive Cancer Network (NCCN) guidelines of care for nonmelanoma skin cancers
13. Skin cancer in liver transplant recipients
14. Nonmelanoma cancers of the skin
15. Mohs' micrographic surgery for nonmelanoma skin cancers
16. Basal cell carcinoma and squamous cell carcinoma: Recognition and treatment
17. Principles of management of basal and squamous cell carcinoma of the skin
18. Basal and squamous cell carcinoma
19. Mohs micrographic surgery: A cost analysis
20. Radiotherapy in the treatment of dermatologic malignancies
21. Cryosurgery for cutaneous malignancy: An update
22. Cryotherapy of nonmelanoma skin cancer
23. Advances in cryosurgery during the past decade
24. Recognition and management of high-risk cutaneous tumors
25. Surgical management of primary melanoma
26. Frozen section analysis in the management of skin cancers
27. Toward the biologic treatment of nonmelanoma skin cancer
28. Role of retinoids in skin cancer treatment and prevention
29. The role of photodynamic therapy in dermatology
30. Concepts of sliding and lifting tissue movement in flap reconstruction
31. Cancer of the forehead and temple regions
32. The epidemiology of skin cancer
33. Management of malignant melanoma
34. Biopsy technique for pigmented lesions
35. Sentinel lymphadenectomy in the management of primary cutaneous malignant melanoma: An update
36. Malignant melanoma: Prevention, early detection, and treatment in the 21st century
37. Narrow excision (1-cm margin): A safe procedure for thin cutaneous melanoma
38. Melanoma
39. The reliability of frozen sections in the evaluation of surgical margins for melanoma
40. Mohs micrographic surgery for the treatment of primary cutaneous melanoma
41. Utility of follow-up tests for detecting recurrent disease in patients with malignant melanomas
42. Current therapy of cutaneous melanoma
43. A new American Joint Committee on Cancer staging system for cutaneous melanoma
44. Role of sentinel node biopsy in the management of malignant melanoma
45. Role for lymphatic mapping and sentinel lymph node biopsy in patients with thick (> or = 4 mm) primary melanoma
46. The orderly progression of melanoma nodal metastases
47. Interferon alfa-2b adjuvant therapy of high-risk resected cutaneous melanoma: The Eastern Cooperative Oncology Group Trial EST 1684
48. Review of sentinel lymph node biopsy and systemic interferon for melanoma: Promising but investigational modalities
49. Computed tomography in evaluation of patients with stage III melanoma
50. Diagnosis and treatment of early melanoma
51. Ultra-late recurrence (15 years or longer) of cutaneous melanoma
52. Computerized digital image analysis: An aid for melanoma diagnosis - Preliminary investigations and brief review
53. Follow-up of melanocytic skin lesions with digital epiluminescence microscopy: Patterns of modifications observed in early melanoma, atypical nevi, and common nevi